Assessment | Biopsychology | Comparative | Cognitive | Developmental | Language | Individual differences | Personality | Philosophy | Social |
Methods | Statistics | Clinical | Educational | Industrial | Professional items | World psychology |

Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Neuroscience · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology (Index, Outline)

This article needs rewriting to enhance its relevance to psychologists..
Please help to improve this page yourself if you can..

Hormonal regulation occurs at every stage of development. A milieu of hormones simultaneously affects development of the fetus during embryogenesis and the mother, perhaps most notably human chorionic gonadotropin (hCG) and progesterone (P4). Psychologists are interested in these processes in as much as psychological processes may affect endocrinology and reproduction, or that these may affect behavior, thoughts or feeling

Embryogenesis Edit

Human chorionic gonadotropin (hCG), progesterone, 17β-estradiol, endorphins and gonadotropin-releasing hormone (GnRH) synthesis are rapidly upregulated by the developing embryo following fertilization of the ovum [1][2][3].

During early embryonic development, paracrine/juxtacrine signaling of hCG induces blastulation and neurulation. An in vitro model of early human embryogenesis (human embryonic stem cells (hESCs)) has demonstrated that hCG promotes cell proliferation via the LH/hCG receptor (LHCGR). hCG signaling upregulates the expression of steroidogenic acute regulatory protein (StAR)-mediated cholesterol transport and the synthesis of progesterone in hESC. The production of progesterone at this time induces embryroid body (akin to blastulation) and rosette (akin to neurulation) formation in vitro. Progesterone induces the differentiation of pluripotent hESC to neural precursor cells [4][5].

Suppression of P4 signaling following withdrawal of progesterone, or treatment with the progesterone receptor antagonist RU-486 (mifepristone), inhibits the differentiation of hESC colonies into embryoid bodies (blastulation) or rosettes (neurulation). RU-486, a drug commonly used to terminate pregnancy in its early stages, acts not only to abort the embryo, but also to inhibit normal embryonic development [4][5].

Influence of Maternal Hormones Edit

Pregnancy-associated hormones such as hCG and sex steroids regulate numerous biological processes in the maternal system prior to and during pregnancy. The embryo orchestrates biological changes that occur in both the embryo and the mother. The embryo upregulates hCG, drives growth of the cell, and upregulates P4 production driving development. hCG and P4 direct changes in the mother to enable successful pregnancy (see below) via upregulation of specific hormones that act to direct both endocrinological and biological changes within the mother for successful pregnancy.

Maintenance of the endometrial lining Edit

The early embryo has 1–2 weeks in order to produce sufficient hCG in order to stabilize the endometrial lining to allow for blastocyst attachment. The dramatic increase in trophoblastic and corpus luteal hCG synthesis signals both blastocyst [5] and corpus luteal [6] production of P4, crucial for the maintenance of the endometrium.

Attachment and invasion of cytotrophoblast into endometrium Edit

hCG secreted by cytotrophoblastic cells of the blastocyst controls endometrial tissue remodeling by both activation of matrix matalloproteinases (MMP) that control the maternal extracellular matrix and inhibition of tissue-inhibitors of matrix-metalloproteinases (TIMP). hCG mediates invasion and attachment to the endometrium [7]. Low levels of hCG increase risk of pre-eclampsia [8].

Uterine angiogenesis Edit

Uterine angiogenesis is upregulated by human chorionic gonadotropin and progesterone and downregulated by estrogen. The balance of influences of progesterone and estrogen determine the state of angiogenesis in the uterus during early pregnancy [9][10].

Suppression of the maternal immune system Edit

High levels of progesterone produced by the embryonic placenta regulate lymphocyte proliferation at the maternal-fetal interface, locally suppressing maternal immune response against the developing embryo [11].

Suppression of GnRH secretion to prevent further follicular maturation Edit

Negative feedback of progesterone inhibits hypothalamic pulsatile GnRH neurosecretion, ovulatory GnRH release and pituitary gonadotropin surges thereby effectively preventing further follicular maturation [12][13][14].

Preparation of maternal metabolic systems Edit

Progesterone regulates metabolism of carbohydrates, proteins, and lipids, resulting in physiological changes associated with pregnancy. The mix of hormones characteristic of early pregnancy promote natural growth of maternal tissues and weight gain [15]. In the second half of pregnancy, progesterone and prolactin prepare the mammary glands for lactation [16].

Preparation of mammary glands for lactation Edit

Estrogens and progesterone promote mammary epithelial cell proliferation resulting in the formation of the primary and secondary ductal structure. Progesterone induces formation of tertiary side-branches in the mammary glands during puberty and during the luteal phase of the menstrual cycle upon which lobuloalveolar structures form under the influence of prolactin. Prolactin stimulates lactogenesis [16][17].

Induction of sleep Edit

hCG appears to be soporific during pregnancy; levels of hCG correlate with sleep changes during pregnancy, and administration of hCG increases sleep in rats likely via neuronal LHCGR [18].

References Edit

  1. Zhuang, L., & Li, R. (1991). Study on reproductive endocrinology of human placenta (II): hormone secreting activity of cytotrophoblast cells. Sci China B., 34, 1092–1097.)
  2. Gerami-Naini, B. et al (2004). Trophoblast differentiation in embryoid bodies derived from human embryonic stem cells. Endocrinology, 145, 1517–1524.
  3. Pidoux, G. et al (2007). Biochemical characterization and modulation of LH/CG-receptor during human trophoblast differentiation. Journal of Cell Physiology, 212, 26–35.
  4. 4.0 4.1 Gallego, M. et al (2009). Opioid and progesterone signaling is obligatory for early human embryogenesis. Stem Cells Development, 18, 737–740.
  5. 5.0 5.1 5.2 Gallego, M. et al (2010). The pregnancy hormones human chorionic gonadotropin and progesterone induce human embryonic stem cell proliferation and differentiation into neuroectodermal rosettes. Stem Cell Research & Therapy, 1, 1-13
  6. Carr, B., MacDonald, P., Simpson, E. (1982). The role of lipoproteins in the regulation of progesterone secretion by the human corpus luteum. Fertil Steril, 38, 303-311
  7. Licht, P. et al (2007). Is human chorionic gonadotropin directly involved in the regulation of human implantation? Molecular and Cellular Endocrinology, 269, 85-92.
  8. Bahado-Singh, R., et al (2002). The role of hyperglycosylated hCG in trophoblast invasion and the prediction of subsequent pre-eclampsia. Prenatal Diagnosis, 22, 478-481.
  9. Ma, W. et al (2001). Adult Tissue Angiogenesis: Evidence for negative regulation by estrogen in the uterus. Molecular Endocrinology, 15, 1983-1992.
  10. Zygmunt M, Herr F, Keller-Schoenwetter S, Kunzi-Rapp K, Münstedt K, Rao CV, Lang U, Preissner KT (2002). Characterization of human chorionic gonadotropin as a novel angiogenic factor. J Clin Endocrinol Metab. 87, 5290-5296.
  11. Clemens, L., Siiteri, P., & Stites, D. (1979). Mechanism of immunosuppression of progesterone on maternal lymphocyte activation during pregnancy. The Journal of Immunology, 122, 1978-1985.
  12. Yen S, et al. Causal relationship between hormonal variables in the menstrual cycle. In Ferin M, Richart RM, Vande Wiele RL (eds). Biorhythms and Human Reproduction. New York, John Wiley and Sons, 1974, pp 219-238.
  13. Zeleznik, A., Fairchild Benyo, D. Control of follicular development, corpus luteum function and the recognition of pregnancy in higher primates. In Knobil E (ed). The Physiology of Reproduction. New York, Raven Press, 1994, pp 751-782.
  14. Sleiter, N., Pang, Y., Park, C., Horton, T., Dong, J., Thomas, P., & Levine, J. (2009). Progesterone Receptor A (PRA) and PRB-Independent Effects of Progesterone on Gonadotropin-Releasing Hormone Release. Endocrinology, 150, 3833-3844.
  15. Kalkhoff, R. (1982). Metabolic effects of progesterone. American Journal of Obstetrician Gynecology, 142, 735-738.
  16. 16.0 16.1 Atwood, C. et al (2000). Progesterone induces side-branching of the ductal epithelium in the mammary glands of peripubertal mice. Journal of Endocrinology, 167, 39-52.
  17. Fantl, V., Edwards, P., Steel, J., Vonderhaar, B., & Dickson, C. (1999). Impaired Mammary Gland Development in Cyl-12/2 Mice during Pregnancy and Lactation Is Epithelial Cell Autonomous. Developmental Biology, 212, 1–11.
  18. Rao, C. et al (1995). Peripheral and intracerebroventricular administration of human chorionic gonadotropin alters several hippocampus-associated behaviors in cycling female rats. Hormones and Behavior, 29, 42-58

This page uses Creative Commons Licensed content from Wikipedia (view authors).

Ad blocker interference detected!

Wikia is a free-to-use site that makes money from advertising. We have a modified experience for viewers using ad blockers

Wikia is not accessible if you’ve made further modifications. Remove the custom ad blocker rule(s) and the page will load as expected.